At a meeting with analysts and investors at its 2025 Investor Day, members of the leadership team of Quest Diagnostics (NYSE: DGX), a leading provider of diagnostic information services, will discuss ...

For decades, the United States has led the world in pharmaceutical innovation – developing drugs that combat cancer, heart ...

An experimental drug appears to reduce the risk of Alzheimer's-related dementia in people destined to develop the disease in ...

An experimental treatment appears to postpone Alzheimer's symptoms in some people genetically destined to get the disease at ...

For the first time, scientists say, they have evidence that using a biologic drug to remove sticky beta amyloid plaques from ...

Since becoming only the second Alzheimer's-modifying drug to gain American Federal Drug Administration approval in 2023, ...

Planned single, pivotal Phase 2/3 clinical trial, if positive, acceptable for Biological License Application (BLA) submission for Alzheimer’s ...

Positive Results with Zervimesine (CT1812) in Phase 2 SHIMMER Dementia with Lewy Bodies (DLB)Phase 2 SHINE Data Show Dramatic Slowing of ...

A crown over a soccer ball. An eyeball that “looked cool.” Flowers. Those are some of the everyday tattoos that defense lawyers say helped lead to the sudden weekend deportation of roughly 200 ...

PeopleBio announced on the 18th that it will launch its Alzheimer’s diagnosis blood test export product 'AlzOn+' at Siriraj ...

MLB, Topps and Nike have partnered to recognize baseball's elite performers from last season with custom gold-embellished MLB logos on their jerseys that will then be used to create trading cards.